[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624092":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":39,"locations":45,"responsibleParty":80,"collaborators":26,"id":82,"slug":83,"hasResults":84,"nctId":85,"briefTitle":86,"officialTitle":86,"acronym":26,"eligibilityCriteria":87,"healthyVolunteers":84,"sex":88,"minAge":89,"maxAge":26,"enrollmentInfo":90,"targetDuration":26,"studyType":93,"phases":94,"briefSummary":96,"conditions":97,"keywords":26,"overallStatus":99,"whyStopped":26,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":109},{"fullName":5,"class":6},"Lumenis Be Ltd.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"study arm","EXPERIMENTAL","subjects in the study arm will receive active IPL treatment",[13],"Device: Active IPL",{"label":15,"type":16,"description":17,"interventionNames":18},"Control arm","SHAM_COMPARATOR","subjects in the control arm will receive sham IPL treatment",[19],"Device: Sham IPL",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Sham IPL","Three sham IPL treatments in 1-week interval followed by 1 follow-up 4 weeks after the last treatment",[15],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Active IPL","Three active IPL treatments in 1-week interval followed by 1 follow-up 4 weeks after the last treatment",[9],[32,36],{"name":33,"affiliation":34,"role":35},"James Chelnis, MD","Manhattan Face and Eye clinic","PRINCIPAL_INVESTIGATOR",{"name":37,"affiliation":38,"role":35},"Laura Periman","Periman Eye Institute",[40],{"name":41,"role":42,"phone":43,"phoneExt":26,"email":44},"Haya Hamza, Bsc","CONTACT","+972527493696","haya.hamza@lumenis.com",[46,61],{"facility":34,"status":26,"city":47,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"New York","10019","United States","US",{"type":52,"coordinates":53},"Point",[54,55],-74.00597,40.71427,{"lat":55,"lon":54},[58,60],{"name":33,"role":42,"phone":26,"phoneExt":26,"email":59},"drchelnis@manhattanfaceandeye.com",{"name":33,"role":35,"phone":26,"phoneExt":26,"email":26},{"facility":38,"status":26,"city":62,"state":63,"zip":64,"country":49,"countryCode":50,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Seattle","Washington","98119",{"type":52,"coordinates":66},[67,68],-122.33207,47.60621,{"lat":68,"lon":67},[71,75,79],{"name":72,"role":42,"phone":73,"phoneExt":26,"email":74},"Laura Periman, MD","206-347-0821","ClinicalTrials@perimaneyeinstitute.com",{"name":76,"role":42,"phone":77,"phoneExt":26,"email":78},"AnaLucia Clarkson","+1 (206) 3470821","concierge@perimaneyeinstitute.com",{"name":72,"role":35,"phone":26,"phoneExt":26,"email":26},{"type":81,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100624092","evaluation-of-effectiveness-and-safety-of-intense-pulsed-light-treatment-for-chalazion-100624092",false,"NCT07405138","Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion","Inclusion Criteria:\n\n* Subject is able to read, understand, and sign an Informed Consent Form (ICF)\n* 18 years of age or older\n* Clinical diagnosis of chalazion in the inflammatory stage\n* Subject is willing to comply with all study procedures-\n\nExclusion Criteria:\n\n* Concurrent eyelid infection\n* Chalazion with atypical features, which to the opinion of the study investigator is inadequate for a study\n* Recurring Chalazion\n* Floppy eyelid syndrome\n* Demodex blepharitis patients taking Lotilaner ophthalmic solution within 30 days prior to screening\n* Ocular surgery within 3 months prior to screening\n* Current diagnosis of malignant tumors in the affected eyelid, including:\n\nsebaceous carcinoma and basal cell carcinoma\n\n* Laser Assisted In Situ Keratomileusis (LASIK)\u002FSmall Incision Lenticule Extraction (SMILE) surgery, within 1 year prior to screening\n* Radial Keratotomy (RK) surgery\n* Recent ocular trauma, within 3 months prior to screening\n* Pre-cancerous lesions or skin cancer in the planned treatment area\n* Severe active allergies, or other severe uncontrolled eye disorders affecting the ocular surface\n* Uncontrolled infections or uncontrolled immunosuppressive diseases\n* Best corrected visual acuity worse than 20\u002F200 in either eye\n* Ocular surface abnormality that may compromise corneal integrity in either eye (e.g., prior chemical burn, Epithelial Basement Membrane Dystrophy - EBMD)\n* Within 1 week prior to screening, use of photosensitive medication and\u002For herbs that may cause sensitivity to 560-1200 nm light exposure, including: Isotretinoin, Tetracycline, Doxycycline, and St. John's Wort\n* Active sun burn in the treatment area\n* Anterior chamber inflammation\n* Corneal edema\n* Any condition revealed w","ALL","18 Years",{"count":91,"type":92},40,"ESTIMATED","INTERVENTIONAL",[95],"NA","To study the effectiveness and safety of IPL treatment for Chalazion",[98],"Chalazion","NOT_YET_RECRUITING","2026-02-17",{"date":102,"type":103},"2026-02-19","ACTUAL",{"date":105,"type":92},"2026-02-04",{"date":107,"type":92},"2026-12",{"name":5,"class":6},2]